
Dexcom Investor Relations Material
Latest events

Q2 2025
Dexcom
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Dexcom Inc
Access all reports
Dexcom, Inc., focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company's products include Dexcom G4 PLATINUM System, Dexcom G5 Mobile CGM System, and its interoperable systems, as well as other clinical diagnostic products. It offers its products to hospitals; physicians' offices specializing in diabetes treatment; ambulatory surgical centers; clinical practice settings; corporate wellness programs; and individual patients. The company markets its products directly to physicians and their specialties, including endocrinologists; general practitioners; obstetricians/gynecologists; pediatricians; family physicians; doctors practicing in health care clinics or managed facilities; diabetologists; and internists. The company was incorporated in 1999.
Key slides for Dexcom Inc


Q2 2025
Dexcom Inc


Raymond James & Associates’ 46th Annual Institutional Investors Conference 2025
Dexcom Inc
Latest articles
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
)
Maziar Mike Doustdar: Novo Nordisk's New CEO
A portrait of the pharmaceutical giant's new CEO, who assumes the position at a critical time for the company in its competition with Eli Lilly.
12 Aug 2025
)
Novo Nordisk: Tipping the Scale of Innovation
Taking a look at the company behind Ozempic and Wegovy and diving into their history, business, and the challenges it now faces
8 Aug 2025
Ticker symbol
DXCM
Country
🇺🇸 United States